Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15,368 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phosphodiesterase 4 inhibitor and phosphodiesterase 5 inhibitor combination therapy has antifibrotic and anti-inflammatory effects in mdx mice with Duchenne muscular dystrophy.
Nio Y, Tanaka M, Hirozane Y, Muraki Y, Okawara M, Hazama M, Matsuo T. Nio Y, et al. Among authors: tanaka m. FASEB J. 2017 Dec;31(12):5307-5320. doi: 10.1096/fj.201700249R. Epub 2017 Aug 10. FASEB J. 2017. PMID: 28798156
In summary, we confirmed that piclamilast has significant antifibrotic effects in mdx mouse muscle and is a potential treatment for muscle fibrosis in DMD.-Nio, Y., Tanaka, M., Hirozane, Y., Muraki, Y., Okawara, M., Hazama, M., Matsuo, T. Phosphodieste …
In summary, we confirmed that piclamilast has significant antifibrotic effects in mdx mouse muscle and is a potential treatment for muscle f …
Pharmacological effects of TAK-828F: an orally available RORγt inverse agonist, in mouse colitis model and human blood cells of inflammatory bowel disease.
Igaki K, Nakamura Y, Tanaka M, Mizuno S, Yoshimatsu Y, Komoike Y, Uga K, Shibata A, Imaichi H, Takayuki S, Ishimura Y, Yamasaki M, Kanai T, Tsukimi Y, Tsuchimori N. Igaki K, et al. Among authors: tanaka m. Inflamm Res. 2019 Jun;68(6):493-509. doi: 10.1007/s00011-019-01234-y. Epub 2019 Apr 10. Inflamm Res. 2019. PMID: 30972425
Hydrogen-Assisted Mg Intercalation into 2H-TaS2.
Fujioka M, Zagarzusem K, Iwasaki S, Sharma A, Watanabe K, Nakayama R, Momai M, Yamaguchi Y, Shimada H, Nomura K, Mizutani Y, Sumi H, Tanaka M, Jeem M, Hattori M, Saitoh H, Ozaki T, Nagao M, Nagashima K. Fujioka M, et al. Among authors: tanaka m. J Am Chem Soc. 2024 Dec 3. doi: 10.1021/jacs.4c07294. Online ahead of print. J Am Chem Soc. 2024. PMID: 39626204
Allogeneic hematopoietic stem cell transplantation using reduced intensity conditioning regimen for patients with acute myeloid leukemia not in complete remission.
Shimomura Y, Kitamura T, Yanada M, Mizuno S, Kondo T, Yoshihara S, Tanaka M, Inai K, Katayama Y, Onizuka M, Fukuda T, Nakamae H, Kurokawa M, Yano S, Nara M, Masuko M, Miyakoshi S, Eto T, Yoshimitsu M, Ishimaru F, Kanda J, Atsuta Y, Konuma T. Shimomura Y, et al. Among authors: tanaka m. Cytotherapy. 2024 Nov 17:S1465-3249(24)00937-X. doi: 10.1016/j.jcyt.2024.11.012. Online ahead of print. Cytotherapy. 2024. PMID: 39625431
Comparison of Nonrelapse Mortality after Haploidentical Hematopoietic Stem Cell Transplantation with Posttransplant Cyclophosphamide Versus Single Umbilical Cord Blood Transplantation in Hematologic Disease.
Harada K, Kanda J, Hirayama M, Wada F, Uchida N, Tanaka M, Nakamae H, Tokunaga M, Ishiwata K, Onizuka M, Hasegawa Y, Fukuda T, Eto T, Kurita N, Kawakita T, Jinguji A, Ishimaru F, Atsuta Y, Nakasone H. Harada K, et al. Among authors: tanaka m. Transplant Cell Ther. 2024 Nov 25:S2666-6367(24)00782-6. doi: 10.1016/j.jtct.2024.11.011. Online ahead of print. Transplant Cell Ther. 2024. PMID: 39603416
15,368 results
You have reached the last available page of results. Please see the User Guide for more information.